A Phase 3 Open-Label, Randomized, Standard of Care-controlled Parallel Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants with Bilateral Lung Transplant

Medicine & Life Sciences

1. Bronchiolitis Obliterans 100%
2. Standard of Care 70%
3. Arm 63%
4. Transplants 45%
5. Safety 42%
6. Lung 38%